Increased serum Trx levels have been noted in patients with NASH- and HCV-related liver diseases, suggesting its potential as a biomarker for oxidative stress and disease severity [26,27,28]. This evidence concerns the gene TXN and metabolic dysfunction-associated steatohepatitis.